Managing Director Dr Maurice Webster, and Head of the Invetus Veterinary Clinical Research Network, Dr Elizabeth Evans, spent two whirlwind days at the AusBiotech annual conference in Adelaide last week. With its focus on research and industry collaboration, the Conference was a great opportunity for Invetus to connect with a range of others in the sector. Over two days, Maurice and Liz had scheduled meetings with almost 20 potential partners or clients, and visited almost all the exhibition booths to touch base with current clients, and also looking for opportunities.
Liz commented “it was such a valuable use of time, and allowed us to introduce Invetus to a range of global and local organisations. Many didn’t realise the breadth of the Invetus offering, from the very beginning of the development cycle, through to commercialisation.”
There was a great deal of interest from the other parties in working with Invetus, and as Maurice said “it gives me great confidence in the future, when I hear first-hand that researchers and facilitators in the industry see an important place for Invetus.”
Invetus will be at next year’s AusBiotech conference, which will be held 31 October - 2 November 2018 at the Brisbane Convention Centre. It is expected to attract more than 800 researchers, investors and industry stakeholders from the life sciences sector, from Australia and around the globe.
AusBiotech is the leading Australian industry body representing and advocating for organisations doing business in and with the global life sciences economy.
AusBiotech has been working on behalf of members for 30 years to provide representation and services to promote the global growth of the Australian life sciences industry. AusBiotech is a well-connected network of over 3,000 members in the life sciences, including therapeutics, medical technology (devices and diagnostics), digital health, food technology and agricultural, environmental and industrial sectors.
The annual AusBiotech conference has brought together Australian and international biotech leaders and stakeholders for more than three decades, creating a forum to reflect on the sector’s achievements and exchange ideas to further advance the sector’s standing both nationally and globally.
AusBiotech is dedicated to consolidating this growth, and our 2017 conference once again presented issues critical to industry. Global biotech trends, breakthroughs, challenges and success stories will feature prominently on the program. Panel discussions and key themes will cover regulation and reimbursement, research translational strategies, new markets, business development and capital access, emerging technologies, clinical trials and commercialisation.